as informed in sciencemag
New vaccine coalition aims to ward off epidemics
New vaccine coalition aims to ward off epidemics
A new public-private coalition that aims to derail epidemics by speeding development of vaccines has now hung its shingle with the backing of the Wellcome Trust and the Bill & Melinda Gates Foundation.The Coalition for Epidemic Preparedness Innovations (CEPI), which launched its website today, grew out of the widespread conviction that vaccines languishing in R&D could have prevented the recent Ebola epidemic in West Africa that killed more than 11,000 people."CEPI is something the world desperately needs, and we've been struggling to create it for several years," says John-Arne Røttingen, who headed the steering committee of an Ebola vaccine trial in Guinea that yielded astonishingly positive results.
additionally wgrz
New 7th & 12th grade vaccine requirements
New 7th & 12th grade vaccine requirements
BUFFALO, N.Y. -- As summer vacation winds down, there's a new state law parents need to know about before kids go back to school.It has to do with a required vaccination.It's the meningococcal vaccine, and children entering 7th and 12th grades are required to get it before starting school.
coupled with cnn
New dengue vaccine could lead to more cases, experts warn
New dengue vaccine could lead to more cases, experts warn
(CNN) This may go against what typically comes to mind when you think about vaccines, but the newly licensed vaccine against the dengue virus -- trade name Dengvaxia -- could lead to an increase in the number of cases of the disease if not implemented correctly, experts warn in a new study .The number of people affected by dengue has increased in recent years , with 390 million people estimated to be infected each year, and cases of the disease have become more global -- with cases reported in more than 100 countries worldwide.The long road to a vaccineDengvaxia was produced by Sanofi Pasteur , which, after spending 20 years developing the vaccine, published promising findings on its effectiveness in 2015.
No comments:
Post a Comment